Nova Eye pioneered the fastest growing segment in the burgeoning ophthalmic market; canal surgery for glaucoma, and holds over 100 patents in this domain
Nova Eye has invested in developing a next generation product (iTrackTM Advance)
The iTrack advance gained FDA approval of Friday 31 Mar. Shares jumped around 25% initially then pulled back for a 5% gain.
FDA approval
I notice there was some activity on strawman a few years ago. Perhaps some strawfolks are able to comment on these new developments;) With the original device still in use the new design should gain widespread adoption fairly soon and it will be interesting to hear progress on the rollout and uptake
![b3fa5ea631783be338879abfac4cebeb977749.jpeg](//strawman.com/member/uploads/objects/a4/b3fa5ea631783be338879abfac4cebeb977749.jpeg)
Company presentation
![492ba857d208a9cf0196f970fc0565c6fea64b.jpeg](//strawman.com/member/uploads/objects/a9/492ba857d208a9cf0196f970fc0565c6fea64b.jpeg)
Held SM and IRL